Haemonetics to Present at Raymond James 43rd Annual Institutional Investors Conference

Rhea-AI Summary

Haemonetics Corporation (NYSE: HAE) announced that CEO Chris Simon will engage in a fireside chat with investors at the Raymond James 43rd Annual Institutional Investors Conference on March 7, 2022, at 9:50 a.m. ET. Interested individuals can access a live webcast through Haemonetics' Investor Relations website, and a replay will be available 12 hours post-event for a year. Haemonetics focuses on innovative healthcare solutions to enhance patient care and reduce costs, particularly in blood and plasma collection, surgical operations, and transfusion services.

BOSTON, Feb. 23, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James 43rd Annual Institutional Investors Conference on Monday, March 7, 2022, at 9:50 a.m. ET.

The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at: https://kvgo.com/rj-43rd-iic/haemonetics-corporation-march-2022

A replay of the recorded webcast will become accessible 12 hours after the event and will be available for one year on Haemonetics' Investor Relations website.

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.      

Investor Contact:	Media Contact:
Olga Guyette, Director-Investor Relations	Josh Gitelson, Director-Global Communications
(781) 356-9763	(781) 356-9776
olga.guyette@haemonetics.com	josh.gitelson@haemonetics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-raymond-james-43rd-annual-institutional-investors-conference-301488959.html

SOURCE Haemonetics Corporation

FAQ

When will Chris Simon participate in the Raymond James 43rd Annual Institutional Investors Conference?

Chris Simon will participate in the conference on March 7, 2022, at 9:50 a.m. ET.

How can I access the live webcast of Haemonetics' fireside chat?

The live webcast can be accessed through Haemonetics' Investor Relations website.

Will there be a replay of Haemonetics' conference presentation?

Yes, a replay will be available 12 hours after the event and accessible for one year.

What is the focus of Haemonetics Corporation?

Haemonetics focuses on providing innovative medical products for blood and plasma collection, surgical aids, and hospital transfusion services.

What is the stock symbol for Haemonetics Corporation?

The stock symbol for Haemonetics is HAE.